Endothelial interleukin-21 receptor up-regulation in peripheral artery disease

Tao Wang, Alexis Cunningham, Kevin Houston, Aditya M. Sharma, Lingdan Chen, Ayotunde Dokun, R. John Lye, Rosanne Spolski, Warren J. Leonard, Brian H. Annex

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In most patients with symptomatic peripheral artery disease (PAD), severe stenosis in or occlusion of the major blood vessels that supply the legs make the amount of distal blood flow dependent on the capacity to induce angiogenesis and collateral vessel formation. Currently, there are no medications that improve perfusion to the ischemic limb, and thus directly treat the primary problem of PAD. A recent report from our group in a pre-clinical mouse PAD model showed that interleukin-21 receptor (IL-21R) is up-regulated in the endothelial cells from ischemic hindlimb muscle. We further showed that loss of IL-21R resulted in impaired perfusion recovery in this model. In our study, we sought to determine whether IL-21R is present in the endothelium from ischemic muscle of patients with PAD. Using human gastrocnemius muscle biopsies, we found increased levels of IL-21R in the skeletal muscle endothelial cells of patients with PAD compared to control individuals. Interestingly, PAD patients had approximately 1.7-fold higher levels of circulating IL-21. These data provide direct evidence that the IL-21R pathway is indeed up-regulated in patients with PAD. This pathway may serve as a therapeutic target for modulation.

Original languageEnglish (US)
Pages (from-to)99-104
Number of pages6
JournalVascular Medicine (United Kingdom)
Volume21
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Interleukin-21 Receptors
Peripheral Arterial Disease
Up-Regulation
Skeletal Muscle
Endothelial Cells
Perfusion
Muscles
Hindlimb
Muscle Cells
Endothelium
Blood Vessels
Leg
Pathologic Constriction
Extremities
Biopsy

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Endothelial interleukin-21 receptor up-regulation in peripheral artery disease. / Wang, Tao; Cunningham, Alexis; Houston, Kevin; Sharma, Aditya M.; Chen, Lingdan; Dokun, Ayotunde; Lye, R. John; Spolski, Rosanne; Leonard, Warren J.; Annex, Brian H.

In: Vascular Medicine (United Kingdom), Vol. 21, No. 2, 01.04.2016, p. 99-104.

Research output: Contribution to journalArticle

Wang, T, Cunningham, A, Houston, K, Sharma, AM, Chen, L, Dokun, A, Lye, RJ, Spolski, R, Leonard, WJ & Annex, BH 2016, 'Endothelial interleukin-21 receptor up-regulation in peripheral artery disease', Vascular Medicine (United Kingdom), vol. 21, no. 2, pp. 99-104. https://doi.org/10.1177/1358863X15621798
Wang, Tao ; Cunningham, Alexis ; Houston, Kevin ; Sharma, Aditya M. ; Chen, Lingdan ; Dokun, Ayotunde ; Lye, R. John ; Spolski, Rosanne ; Leonard, Warren J. ; Annex, Brian H. / Endothelial interleukin-21 receptor up-regulation in peripheral artery disease. In: Vascular Medicine (United Kingdom). 2016 ; Vol. 21, No. 2. pp. 99-104.
@article{b24e1cca32834077a8d2deafb8ad9c91,
title = "Endothelial interleukin-21 receptor up-regulation in peripheral artery disease",
abstract = "In most patients with symptomatic peripheral artery disease (PAD), severe stenosis in or occlusion of the major blood vessels that supply the legs make the amount of distal blood flow dependent on the capacity to induce angiogenesis and collateral vessel formation. Currently, there are no medications that improve perfusion to the ischemic limb, and thus directly treat the primary problem of PAD. A recent report from our group in a pre-clinical mouse PAD model showed that interleukin-21 receptor (IL-21R) is up-regulated in the endothelial cells from ischemic hindlimb muscle. We further showed that loss of IL-21R resulted in impaired perfusion recovery in this model. In our study, we sought to determine whether IL-21R is present in the endothelium from ischemic muscle of patients with PAD. Using human gastrocnemius muscle biopsies, we found increased levels of IL-21R in the skeletal muscle endothelial cells of patients with PAD compared to control individuals. Interestingly, PAD patients had approximately 1.7-fold higher levels of circulating IL-21. These data provide direct evidence that the IL-21R pathway is indeed up-regulated in patients with PAD. This pathway may serve as a therapeutic target for modulation.",
author = "Tao Wang and Alexis Cunningham and Kevin Houston and Sharma, {Aditya M.} and Lingdan Chen and Ayotunde Dokun and Lye, {R. John} and Rosanne Spolski and Leonard, {Warren J.} and Annex, {Brian H.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1177/1358863X15621798",
language = "English (US)",
volume = "21",
pages = "99--104",
journal = "Vascular Medicine",
issn = "1358-863X",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Endothelial interleukin-21 receptor up-regulation in peripheral artery disease

AU - Wang, Tao

AU - Cunningham, Alexis

AU - Houston, Kevin

AU - Sharma, Aditya M.

AU - Chen, Lingdan

AU - Dokun, Ayotunde

AU - Lye, R. John

AU - Spolski, Rosanne

AU - Leonard, Warren J.

AU - Annex, Brian H.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - In most patients with symptomatic peripheral artery disease (PAD), severe stenosis in or occlusion of the major blood vessels that supply the legs make the amount of distal blood flow dependent on the capacity to induce angiogenesis and collateral vessel formation. Currently, there are no medications that improve perfusion to the ischemic limb, and thus directly treat the primary problem of PAD. A recent report from our group in a pre-clinical mouse PAD model showed that interleukin-21 receptor (IL-21R) is up-regulated in the endothelial cells from ischemic hindlimb muscle. We further showed that loss of IL-21R resulted in impaired perfusion recovery in this model. In our study, we sought to determine whether IL-21R is present in the endothelium from ischemic muscle of patients with PAD. Using human gastrocnemius muscle biopsies, we found increased levels of IL-21R in the skeletal muscle endothelial cells of patients with PAD compared to control individuals. Interestingly, PAD patients had approximately 1.7-fold higher levels of circulating IL-21. These data provide direct evidence that the IL-21R pathway is indeed up-regulated in patients with PAD. This pathway may serve as a therapeutic target for modulation.

AB - In most patients with symptomatic peripheral artery disease (PAD), severe stenosis in or occlusion of the major blood vessels that supply the legs make the amount of distal blood flow dependent on the capacity to induce angiogenesis and collateral vessel formation. Currently, there are no medications that improve perfusion to the ischemic limb, and thus directly treat the primary problem of PAD. A recent report from our group in a pre-clinical mouse PAD model showed that interleukin-21 receptor (IL-21R) is up-regulated in the endothelial cells from ischemic hindlimb muscle. We further showed that loss of IL-21R resulted in impaired perfusion recovery in this model. In our study, we sought to determine whether IL-21R is present in the endothelium from ischemic muscle of patients with PAD. Using human gastrocnemius muscle biopsies, we found increased levels of IL-21R in the skeletal muscle endothelial cells of patients with PAD compared to control individuals. Interestingly, PAD patients had approximately 1.7-fold higher levels of circulating IL-21. These data provide direct evidence that the IL-21R pathway is indeed up-regulated in patients with PAD. This pathway may serve as a therapeutic target for modulation.

UR - http://www.scopus.com/inward/record.url?scp=84961249694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961249694&partnerID=8YFLogxK

U2 - 10.1177/1358863X15621798

DO - 10.1177/1358863X15621798

M3 - Article

VL - 21

SP - 99

EP - 104

JO - Vascular Medicine

JF - Vascular Medicine

SN - 1358-863X

IS - 2

ER -